Atlas Logo
Tuberous Sclerosis 2000 (TS 2000)
Tuberous Sclerosis 2000 logo
BACK
Sample details

The TS 2000 Study aims to document and describe the lifetime of someone with Tuberous Sclerosis (TSC), and to identify factors that may lead to intellectual, cognitive, and psychiatric difficulties. Phase one (2001-2005) involved the recruitment and assessment of 125 children aged 0 to 16 years, living in the United Kingdom with TSC. Participants were followed up in phase two (2013-2015), three (2015-2017), and four (2023-2025). Phase four also involved the assessment of additional participants.

Study design
Cohort, Cohort - clinical

Number of participants at first data collection

125 (participants)

Age at first data collection

0 - 16 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Children and young people
Newborns, infants and babies
Patients and clinical populations
Dataset details
Loading map...

Countries

England, Northern Ireland, Scotland, United Kingdom of Great Britain and Northern Ireland, Wales

Year of first data collection

2001

Primary Institutions

King's College London (KCL) (Academic, United Kingdom)

Links

ts2000study.co.uk/

Funders

Autism Speaks (Third Sector, United States of America)

Baily Thomas Charitable Fund (Third Sector, United Kingdom)

Isaac Newton Trust (Third Sector, United Kingdom)

Tuberous Sclerosis Association (Third Sector, United Kingdom)

Ongoing?
Yes

Data types collected

neuroImagingData
mentalHealthData
dataLinkage
Quantitative data collection
  • Activity log (e.g. food, sleep, exercise)
  • Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
  • Interview – phone
  • Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
  • Secondary data
  • Self-completed questionnaire – unspecified
Qualitative data collection
  • None
Neuroimaging data collection
  • Computerized tomography (CT)
  • Magnetic Resonance Imaging (MRI)
Linked or secondary data
  • Healthcare data
Features

Engagement

  • Participant or community advisory groups
  • Community engagement
  • Keywords

    Biological samples/biospecimens
    Child outcomes
    Childhood chronic diseases
    Cognitive impairment and disorders
    Genetic analysis
    Intelligence
    Neurodevelopment
    Paediatric development
    Rare illnesses
    Seizures
    Tuberculosis
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2026 Louise Arseneault

    Platform by Delosis